| Market Capitalization (Millions $) |
450 |
| Shares
Outstanding (Millions) |
28 |
| Employees |
111 |
| Revenues (TTM) (Millions $) |
55 |
| Net Income (TTM) (Millions $) |
-79 |
| Cash Flow (TTM) (Millions $) |
-60 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Arcturus Therapeutics Holdings Inc (Arcturus) is a clinical stage biopharmaceutical company engaged in the discovery, development, and commercialization of RNA medicines. The company is headquartered in San Diego, California, and was founded in 201
Arcturus has developed a proprietary mRNA drug delivery platform called STARR (Self-Transcribing Active Replicating RNA). This platform allows for rapid and flexible development of RNA medicines that can target a variety of diseases. The main focus of the company is on developing RNA medicines for the treatment of rare diseases and vaccines for infectious diseases.
The company has a pipeline of RNA medicines at various stages of development. ARCT-021 is the lead product candidate, which is being developed in collaboration with Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson). This candidate is being developed for the treatment of COVID-19 and is currently in Phase 2 clinical trials.
Arcturus is also developing ARCT-810, a potential treatment for ornithine transcarbamylase (OTC) deficiency, a rare genetic disorder. The company has received orphan drug designation for this candidate from the US FDA.
In addition to its own pipeline, Arcturus has formed partnerships with other pharmaceutical companies to develop RNA medicines for various indications. The company has partnerships with Ultragenyx Pharmaceutical and CureVac for the development of RNA medicines for rare diseases.
Arcturus has also entered into strategic alliances with various companies such as Thermo Fisher Scientific, Duke-NUS Medical School, and others to further advance its mRNA technology platform.
Arcturus has a strong management team with expertise in RNA technology, drug discovery, and development. The company has raised capital through various sources, including public offerings, private placements, and collaborations. As of 2021, the company has a market capitalization of approximately $4 billion.
Company Address: 10285 Science Center Drive San Diego 92121 CA
Company Phone Number: 900-2660 Stock Exchange / Ticker: NASDAQ ARCT
|
0.36% 
29.6 %